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Introduction
Aortic valve repair (AVr) has emerged as a safe, feasible 
and effective alternative to valve replacement in patients 
with aortic insufficiency (AI) (1-4). This owes to a number 
of advances in the field, including better understanding of 
the functional anatomy of the aortic valve (AV), awareness 
of the mechanisms that cause AI and the development of a 
universal classification system that improves clinical practice 
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Background: To evaluate the effect of higher post-operative valve gradient on freedom from valve re-
intervention and death in patients undergoing aortic valve repair (AVr).
Methods: Patients who underwent AVr between March 1996 and June 2010 were divided into 2 groups: I: 
peak gradient (PG) <20 mmHg (n=358) and II: PG ≥20 mmHg (n=113). Age (53.6±16.0 vs. 50.6±16.4 years; 
P=0.08), impaired LV (n=44, 12.2% vs. n=12, 10.6%: P=0.73) as well as the body surface area (1.97 vs. 1.95 
m2; P=0.4) were similar. Pre-operative AI >2+ was greater in Group II compared to Group I (n=78, 69.0% vs. 
n=192, 53.6 %; P=0.004). Patients in Group II had higher proportion of bicuspid valves (BV) (n=58, 51.3% vs. 
n=106, 29.6%; P=0.0001) and restrictive valves (n=34, 30.0% vs. n=52, 14.5%; P=0.0001) while Marfan patients 
were seen only in Group I (n=19; P=0.010). Mean follow-up for Group I and Group II was 123.1±89.7 and 
147.1±108.0 months, respectively. 
Results: In-hospital mortality was n=2 (0.5%) for Group I and none for Group II (P=1.0). Valve-sparing 
was higher in Group I (P=0.0001) but sub-commissural annuloplasty was similar (P=0.15). Shaving and/
or decalcification was performed more in Group II (n=68, 60.1% vs. n=117, 32.6%; P=0.0001). Logistic 
regression analysis identified calcified, restrictive and bicuspid valves as independent predictors of PG ≥ 
20 mmHg (P=0.04 for each). Predictors of re-operation were increased end-diastolic diameter (P=0.03) and 
younger age (P=0.007), but not PG ≥20 mmHg (P=0.98) (based on logistic regression). Overall 10-year 
cardiac survival and freedom from AV re-intervention was 82.3±4.6% vs. 89.5±4.2% (P=0.53) and 89.1±3.0% 
vs. 76.8±8.4% (P=0.02), in Group I and II, respectively (based on Kaplan-Meier analysis). Sub-group analysis 
showed that Group II patients requiring re-intervention (n=10) were younger (41.8±13.1 vs. 51.0±16.0 years; 
P=0.08) with similar proportion of bicuspid valves (n=6; 60%; P=0.74). The main reason for AV re-operation 
was aortic insufficiency (n=7) and AI + stenosis (n=3).
Conclusions: Higher gradient after AVr is associated with a reduced freedom from AV re-intervention, 
especially in younger patients.
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and research (5-7). The advantages of AVr over traditional 
valve replacement (AVR) pertain to the preservation of the 
native aortic valve. This has been shown to reduce long-
term valve-related complications and to negate the risk of 
major haemorrhage associated with lifelong anticoagulation 
in patients requiring mechanical prostheses (1,2). Concerns 
do exist, however, regarding the durability of reparative 
techniques, and freedom from AV re-intervention is therefore 
an important outcome especially in younger patients with 
greater life expectancy. 
If AVr is to supersede AVR as the treatment of choice in 
patients with pure AI, then it is necessary to accurately assess 
repair durability and the factors that contribute to AV re-
intervention. Previously, it has been shown that risk factors for AV 
re-intervention following AVr include younger age (8), bicuspid 
leaflet morphology (9), commissural orientation (8), use of a 
pericardial patch (8), aorto-ventricular junction diameter (8), 
post-operative effective cusp height (8) and the presence of 
pre-discharge AI (10). To date, no study has considered the 
impact of post-operative AV gradient on the need for AV re-
intervention after AVr. This is despite the fact that higher 
post-operative AV gradient has been shown to be associated 
with the need for re-operation after AVR, such as in patient-
prosthesis mismatch, acute implant thrombosis or pannus 
formation (11,12). Higher post-operative gradient may also 
be a modifiable risk factor in that it may be detectable at the 
time of surgery with transoesophageal echocardiography 
(TOE), allowing early correction (13). This study, therefore, 
aimed to evaluate the impact of raised post-operative AV 
gradient on freedom from AV re-intervention after AVr, 
especially in younger patients. 
Methods
Study population and investigations
This study comprised a retrospective analysis of prospectively 
collected data on patients undergoing AVr at a single institution 
between March 1996 and June 2010. The local institutional 
review board waived the requirement for participant consent. 
Patients were included in the study if they had a diagnosis of 
AI and had undergone AVr including techniques to repair or 
replace the aortic sinuses, root or ascending aorta. The sole 
exclusion criterion was patients aged less than 18 years of age 
at the time of operation. All aortic valve leaflet conformations 
were permitted. Routine pre-operative investigations included 
echocardiography to determine the severity of AI, aortic leaflet 
conformation, left ventricular (LV) function, and cardiac and 
aortic dimensions. Coronary angiography was also performed 
in selected patients to evaluate the need for concomitant 
coronary artery bypass grafting (CABG). 
Surgical technique
The surgical technique and principles for tricuspid and 
bicuspid AVs has been described by our group elsewhere (1,3,7).
Echocardiography
Postoperative echocardiography was performed before 
discharge to determine the peak AV gradient and to assess 
potential complications. Patients were divided into two groups 
on the basis of postoperative peak AV gradient. Group I 
comprised those with a peak AV gradient <20 mmHg, while 
Group II included those with a peak AV gradient ≥20 mmHg. 
We chose 20 mmHg as the cut-off peak gradient as we felt 
that this may represent the value signifying the beginning 
of increased turbulence across the valve before ‘stenosis’ 
develops. After discharge patients were followed up at 6 weeks, 
6 months and yearly thereafter.
Data collection and outcomes
Data were collected from bespoke hospital databases 
maintained prospectively. This included details of 
participant demographics (age, gender, height, weight, body 
surface area), pre-operative echocardiographic parameters, 
operative characteristics (nature and duration of surgical 
procedure performed, pathological findings, concomitant 
procedures), early postoperative events (mortality, 
complications, residual AI and AV gradient) and follow-
up details (duration of follow-up, cardiac survival, need for 
valve re-intervention, echocardiographic parameters). 
The primary outcomes were freedom from AV re-
intervention, overall survival and cardiac survival. Freedom 
from AV re-intervention was defined as the time from 
the day of AVr to the day of any surgical or percutaneous 
reoperation on the native AV. Overall survival was defined 
as death from any cause from the date of surgery to final 
follow-up. Cardiac survival was defined as death from 
any heart-related cause from the date of surgery to final 
follow-up, including secondary to any potential valve-
related sequelae (e.g., thromboembolism, endocarditis and 
haemorrhage). Patients lost to follow-up were censored 
at the date of last contact. Secondary outcomes included 
in-hospital mortality (defined as death from any cause 
within 30 days of surgery and/or during the index hospital 
admission), early complications (<30 postoperative days), 
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late valve-related events (>30 postoperative days) and 
echocardiographic outcomes (AI grade, AV area, AV 
gradient, LV function, LV dimensions, aortic dimensions).
Statistical analyses
Statistical analyses were performed using Stata version 11 
(StataCorp, College Station, Texas, USA). Data is expressed 
as mean ± standard deviation or median with range, as 
appropriate. To compare continuous variables either the 
student’s unpaired t-test or Mann-Whitney U test were 
used. For categorical variables, the Chi-squared or Fisher’s 
exact tests were utilised. The Kaplan-Meier method was 
used to evaluate time-dependent variables and comparisons 
were made between groups using the logrank test of 
equality. Logistic regression analysis was used to determine: 
(i) pre-operative predictors of early post-operative peak AV 
gradient ≥20 mmHg; and (ii) independent predictors of AV 
re-intervention at final follow-up. One subgroup analysis 
was planned a priori and this examined the demographic 
and clinical differences between Group I and II patients 
who underwent AV re-intervention. A P-value of <0.05 was 
considered statistically significant. 
Results
Patients
A total of 471 patients met the eligibility criteria and were 
included in the study. These were categorised into 358 
patients in Group I and 113 in Group II on the basis of early 
postoperative peak AV gradient, as discussed before. The 
pre-operative demographic and clinical details of patients 
are listed in Table 1. The mean age of participants in Groups 
Table 1 Showing univariate comparison of preoperative characteristics between Group I (PG <20 mmHg, N=358) and II (PG ≥20 mmHg, N=113)
Preoperative characteristic Group I (%) Group II (%) P value
Male gender 294 (82.1) 88 (77.8 ) 0.33
Mean age in years (SD) 53.6±16.0 50.6±16.4 0.08
Body surface area 1.97±0.2 1.95±0.2 0.42
Marfan (%) 19 (5.3) 0 0.01
Ejection fraction <50% (%) 44 (12.2) 12 (10.6) 0.73
AI >2+ 192 (53.6) 78 (69.0) 0.004
Previous surgery (%) 33 (9.2) 6 (5.3) 0.24
Ross 20 1 -
MVR 3 1 -
CABG 3 1 -
Congenital 3 3 -
Pericardiectomy 1 0 -
AVr 3 0 -
Preoperative echocardiography (%)
Bicuspid valve 106 (29.6) 58 (51.3) 0.0001
Mean LVEDD 57.9±9.1 mm 61.1±8.2 mm 0.001
Mean LVESD 39.0±9.6 mm 41.3±7.8 mm 0.02
Aortic dilatation 252 (70.3) 52 (46.0) 0.0001
Maximum aortic dilatation 49.6±8.5 mm 45.7±9.9 mm 0.0007
Annulus 27.6±3.2 mm 26.8±3.5 mm 0.15
Sinus 41.5±5.9 mm 39.1±7.1 mm 0.02
STJ 37.5±6.1 mm 34.3±7.3 mm 0.005
Ascending aorta 44.4±9.1 mm 42.2±10.4 mm 0.17
SD, standard deviation; AI, aortic insufficiency; MVR, mitral valve replacement; CABG, coronary artery bypass grafting; AVr, 
aortic valve repair; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; STJ, sino-tubular 
junction
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I and II were 53.6±16.0 and 50.6±16.4 years, respectively 
(P=0.08). There were 294 males (82.1%) in Group I and 88 
males (77.8%) in Group II (P=0.33). Impaired LV function 
(n=44, 12.2% vs. n=12, 10.6%; P=0.73) and body surface 
area (1.97 vs. 1.95 m2; P=0.4) were similar between groups. 
A number of baseline differences existed between the two 
groups. More patients in Group II had pre-operative AI 
grade >2+ (n=78, 69.0% vs. n=192, 53.6%; P=0.004), bicuspid 
valves (BV; n=58, 51.3% vs. n=106, 29.6%; P=0.0001) and 
restrictive valves (n=34, 30.0% vs. n=52, 14.5%; P=0.0001), 
while Marfan patients were present only in Group I (n=19; 
P=0.010). In addition, pre-operative echocardiography 
demonstrated that patients in Group II had greater left 
ventricular end-diastolic diameter (LVEDD) and left 
ventricular end-systolic diameter, while the dimensions of 
the aortic sinuses, sino-tubular junction and ascending aorta 
were generally larger in Group I. 
Operative details
Table 2 summarises the operative details. The mean 
cardiopulmonary bypass time was 117.0±68.2 minutes in Group 
I and 105.3±36.2 minutes in Group II (P=0.08). In Group I, 
the mean aortic cross clamp time was 99.3±41.0 minutes as 
compared to 82.8±32.7 minutes in Group II (P=0.0001). 
More valve-sparing, re-implantation and re-modelling 
procedures were performed in Group I, while there was 
a greater proportion of ascending aorta replacements and 
shaving and/or decalcification interventions in Group II. 
Concomitant procedures were performed in 106 patients in 
Group I (29.6%) and 42 patients in Group II (36.2%; P=0.4). 
Amongst these were  some 63 mitral valve (MV) repairs, 53 
CABGs and 15 tricuspid valve (TV) repairs. 
Early postoperative outcomes
There were two cases of in-hospital mortality in Group I (0.5%) 
and none in Group II (0.0%; P=1.0). Early complications 
(<30 days post surgery) are shown in Table 3. There were 
no cases of endocarditis or cerebrovascular events and no 
difference in complication rates between groups. Seven 
patients required early AV re-intervention within 30 days post 
surgery (Group I: n=5, Group II: n=2; P=0.67). At discharge, 
no patients had AI grade >2+ in either Group I or II. 
Late postoperative outcomes
Mean follow-up for Groups I and II was 123.1±89.7 and 
147.1±108.0 months (P=0.01), respectively. During this time 
there were 34 deaths in Group I (9.4%) and 10 deaths in 
Group II (8.8%; P=1.0). Twenty deaths (5.5%) in Group 
I and 6 (5.3%) in Group II were cardiac-related (P=1.0). 
Kaplan-Meier analysis demonstrated similar overall survival 
between the two groups (log-rank P=0.55). At 5-years, 
overall survival was 94.1±0.3% in Group I and 89.1±0.4% 
in Group II, while at 10 years it was 73.6±0.9% in Group I 
and 54.0±2.4% in Group II (Figure 1). Cardiac survival was 
also similar between the two groups (logrank P=0.53). At 5 and 
10 years it was 96.5±0.2% and 92.0±0.4% and 82.2±0.9% and 
89.6±0.5%, in Group I and II, respectively (Figure 2). 
Late complications (>30 days post surgery) are shown 
in Table 4. Atrial fibrillation, stroke, pacemaker insertion 
and endocarditis were similar between the two groups. The 
mean echocardiographic follow-up was 55.0±39.0 months in 
Group I and 45.2±35.7 months in Group II (P=0.0001). The 
mean AV gradient at final follow-up was 12.0±11.9 mmHg 
in Group I compared to 16.8±11.1 mmHg in Group II 
(P=0.04). At final follow-up 22 patients were AI grade >2+ in 
Group I (6.1%), while 11 were in Group II (9.7%; P=0.20). 
Kaplan-Meier analysis demonstrated that freedom from AI > 
2+ was longer in Group I than in Group II (P=0.03). At 5 
and 10 years, freedom from AI >2+ was 94.4±0.3% versus 
88.4±0.4%, and 83.6±0.7% versus 74.4±0.9% in Groups I 
and II respectively (Figure 3). Overall, AV re-intervention 
was required in 28 patients during follow-up (Group I: 
n=18, 5.0%; Group: n=10, 8.8%; P=0.16), of which 21 were 
considered late procedures (performed >30 days after the 
primary intervention). As determined by Kaplan-Meier 
analysis, freedom from AV re-intervention was significantly 
longer in patients in Group I compared to Group II (logrank 
P=0.02). At 5-years, freedom from AV re-intervention 
was 95.2±0.3% in Group I while 91.9±0.3% in Group II. 
Similarly, at 10-years after surgery, freedom from AV re-
intervention was 89.2±0.6% in Group I and 76.9±0.9% in 
Group II (Figure 4). Sub-group analysis showed that Group 
II patients requiring late AV re-intervention (n=10) were 
younger (41.8±13.1 vs. 51.0±16.0 years; P=0.08) with a 
similar proportion of bicuspid valves (n=6; 60%; P=0.74). 
The reasons for AV re-intervention in this subgroup were 
recurrent AI (n=7) and combined AI and stenosis (n=3). 
Multivariate analysis
All baseline covariates that differed significantly between 
the two groups were entered into a logistic regression 
model to analyse predictors of early postoperative peak 
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Table 2 Showing univariate comparison of operative characteristics between Group I (PG <20 mmHg, N=358) and II (PG ≥20 mmHg, N=113)
Operative characteristic Group I (%) Group II (%) P value
Cardiopulmonary bypass time 117.0±68.2 mins 105.3±36.2 mins 0.08
Cross clamp time 99.3±41.0 mins 82.8±32.7 mins 0.0001
Operations
Sparing only 75 (20.9) 6 (5.3) 0.0001
Valve sparing plus leaflet repair 130 (36.3) 21 (18.5) 0.0003
Ascending aorta replacement only 49 (13.6) 25 (22.1) 0.03
Ascending aorta replacement plus annuloplasty 39 (10.8) 22 (19.4) 0.02
Ascending aorta replacement plus leaflet repair 17 (4.7) 16 (14.1) 0.002
Leaflet repair only 14 (3.9) 8 (7.0) 0.19
Leaflet repair plus annuloplasty 82 (22.9) 46 (40.7) 0.0004
Annuloplasty only 9 (2.5) 5 (4.4) 0.33
Re-implantation 160 (44.6) 22 (19.4) 0.0001
Remodelling 24 (6.7) 1 (0.8) 0.01
Tricuspid valve repair N=252 N=55
Plication 69 (27.3) 16 (29.0) 0.86
Triangular resection 9 (3.5) 0 0.37
Goretex reinforcement 54 (21.4) 8 (14.5) 0.35
Sub-commissural annuloplasty 115 (45.6) 42 (76.3) 0.0001
STJ plication 22 (8.7) 9 (16.3) 0.13
Bicuspid valve repair N=106 N=58
Raphe repair 69 (65.0) 44 (75.8) 0.16
Shaving 20 (18.8) 7 (12.0) 0.37
Direct suture 43 (40.5) 28 (48.2) 0.41
Suture and patch 11 (10.3) 10 (17.2) 0.22
Plication 40 (37.7) 12 (20.6) 0.03
Goretex reinforcement 50 (47.1) 30 (51.7) 0.62
Sub-commissural annuloplasty 38 (35.8) 37 (63.7) 0.001
STJ plication 3 (2.80) 6 (10.3) 0.06
Other techniques
Shaving & decalcification 56 (15.6) 33 (29.2) 0.002
Shaving 43 (12.0) 22 (19.4) 0.059
Decalcification 18 (5.0) 13 (11.5) 0.02
Prosthesis 
Straight graft 151 (42.1) 41 (36.2) 0.02
Valsalva 105 (29.3) 13 (11.5) -
Overall leaflet pathology
Calcification and fibrosis 50 (13.9) 29 (25.6) 0.005
Calcification 27 (7.5) 18 (15.9) 0.01
Fibrosis 27 (7.5) 21 (18.5) 0.002
Fenestration 15 (4.1) 3 (2.6) 0.58
Prolapse 189 (52.7) 59 (52.2) 0.91
Restriction 52 (14.5) 34 (30.0) 0.0004
Table 2 (continued)
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Table 2 (continued)
Operative characteristic Group I (%) Group II (%) P value
Bicuspid leaflet pathology 
Prolapse 84 (79.2) 41 (70.6) 0.25
Coronary leaflet 66 (78.5) 38 (92.6) -
Non-coronary leaflet 29 (34.5) 6 (7.4) -
Tricuspid leaflet pathology 
Prolapse 105 (41.6) 18 (32.7) 0.22
Non-coronary leaflet 36 (34.2) 3 (16.6) -
Right coronary leaflet 71 (67.6) 11 (61.1) -
Left coronary leaflet 24 (22.8) 8 (44.4) -
Concomitant procedures 106 (29.6) 41 (36.2) 0.20
MVR 6 (1.6) 2 (1.7) -
MV Repair 39 (10.8) 24 (21.2) -
CABG 41 (11.4) 12 (10.6) -
TV Repair 10 (22.7) 5 (4.4) -
Closure of foramen ovale 6 (1.6) 2 (1.7) -
Arch repair 8 (2.2) 3 (2.6) -
Elephant trunk 5 (1.3) 0 -
Dor 3 (0.8) 0 -
VSD closure 2 (0.5) 0 -
Maze 4 (1.1) 1 (0.8) -
Excision atrial myxoma 3 (0.8) 0
Median prosthesis size (range) 26 (22-32) mm 28 (22-34) mm 0.0005
STJ, sino-tubular junction; MVR, mitral valve replacement; CABG, coronary artery bypass grafting; TV, tricuspid valve; VSD, 
ventricular septal defect
Table 3 Showing univariate comparison of early postoperative outcomes between Group I (PG <20 mmHg, N=358) and II (PG ≥20 mmHg, N=113)
Postoperative characteristic Group I (%) Group II (%) P value
In-hospital mortality (%) 2 (0.5) 0 1.0
Early complications
PPM insertion 11 (3.0) 2 (1.7) 0.74
Thrombo-embolism 11 (3.0) 4 (3.5) 0.76
Re-exploration for bleeding 50 (13.9) 14 (12.3) 0.75
Endocarditis 3 (0.8) 1 (0.8) 1.0
Cerebrovascular event 2 (0.5) 3 (2.6) 0.09
Sternal wound infection 4 (1.1) 1 (0.8) 1.0
Aortic insufficiency at discharge
Grade 0/1+ 337 (94.1) 107 (94.6) 1.0
Grade ≥2+ 21 (5.8) 6 (5.3) -
PPM, permanent pacemaker
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Figure 1 Kaplan-Meier curve showing the difference in overall 
survival between Group I (PG <20 mmHg) and  II (PG ≥20 mmHg) 
at different time periods
Figure 2 Kaplan-Meier curve showing the difference in freedom 
from cardiac death between Group I (PG <20 mmHg) and II (PG ≥ 
20 mmHg) at different time periods
Table 4 Showing univariate comparison of long-term outcomes between Group I (PG <20 mmHg, N=358) and II (PG ≥20 mmHg, N=113)
Follow-up characteristic Group I (%) Group II (%) P valve
Period of TTE follow-up 55.0±39.0 mths 44.9±35.3 mths 0.001
Late overall mortality 34 (9.4) 10 (8.8) 1.0
Cardiac-related mortality 20 (5.5) 6 (5.3) 1.0
NYHA
Class I/II 348 (97.2) 108 (95.5) 0.21
Class III/IV 10 (2.7) 5 (4.4) -
Complications
Atrial fibrillation 22 (6.1) 4 (3.5) 0.35
PPM 15 (4.1) 6 (5.3) 0.60
CVA 11 (3.0) 2 (1.7) 0.74
Endocarditis 3 (0.8) 1 (0.8) 1.0
Aortic insufficiency at last follow-up
Grade 0/1+ 281 (78.4) 82 (72.5) 0.20
Grade ≥2+ 77 (21.5) 31 (27.4) -
Cardiac re-operation 29 (8.1) 10 (8.8) 0.84
AV re-operation 18 (5.0) 10 (8.8) 0.16
Early 5 (1.3) 2 (1.7) 0.67
Late 13 (3.6) 8 (7.0) 0.12
Peak aortic valve gradient 15.4±8.5 mmHg 24.8±10.6 mmHg 0.0002
Mean aortic valve gradient 12.0±11.9 mmHg 16.8±11.1 mmHg 0.04
TTE, trans-thoracic echocardiogram; NYHA, New York Heart Association Classification; PPM, permanent pacemaker; CVA, 
cerebro-vascular accident; AV, aortic valve
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AV gradient ≥20 mmHg. This identified calcified, 
restrictive and bicuspid valves as independent predictors 
of early postoperative AV gradient ≥20 mmHg (P=0.04 
for each). Similarly, a logistic regression model was set up 
to identify independent predictors of the need for AV re-
intervention at final follow-up. This demonstrated that 
increased preoperative end-diastolic diameter (P=0.03) and 
younger age (P=0.007), but not PG≥20 mmHg (P=0.98), 
were independent predictors of AV re-intervention during 
follow-up. 
Discussion
This study investigated the impact of higher early 
postoperative peak AV gradient on long-term outcome after 
AVr. Here, we have shown that AVr is safe and effective 
both in terms of operative morbidity and mortality, long-
term survival and freedom from AV re-intervention. It is 
important to note that pre-operatively, severe AI was greater 
in the group with the higher post-operative gradient. 
Moreover, patients with a higher post-operative gradient 
were more likely to have bicuspid valves and restrictive 
valves pre-operatively. Intrinsically, this leads one to believe 
that patients with a higher post-operative gradient had 
more complex cusp repairs (decalcification and shaving) for 
associated worse AI and complex valve pathology than those 
with lower post-operative gradients. This was also borne 
out from the logistic regression showing that restrictive, 
calcified and bicuspid valves were more likely to have higher 
gradients. 
We have also demonstrated that patients with higher 
post-operative peak AV gradients were more likely to have 
recurrence of AI and require AV re-intervention during 
follow-up, although their survival was not significantly 
affected by this. In the regression analysis of the whole 
cohort, younger patients were more likely to require re-
operation. Furthermore, younger patients in the higher 
gradient group were more likely to require late AV re-
intervention than older ones. The reason for this could 
be three-fold: one, that in patients with a higher gradient, 
the repair may not hold in the long-term leading to 
insufficiency. Secondly, the velocity of blood may 
perpetuate future calcification and stenosis. Thirdly, there 
may be progression of native disease. All these assume 
more significance in younger patients as they are likely 
to live longer. In these circumstances, the peri-operative 
utilisation of imaging techniques to identify those at risk 
or the application of surgical techniques that reduce the 
likelihood of raised transvalvular gradients may be beneficial 
in reducing the need for AV re-intervention. 
Few studies have considered the impact of raised early 
post-operative AV gradient on long-term outcomes of 
AVr. Indeed, reviews of the literature undertaken both in 
the preparation of this manuscript and also by Petterssen 
et al. (14) found no studies that have investigated the 
impact of early post-operative transvalvular gradient on 
the durability of AVr. The latter did, however, hypothesise 
that raised early post-operative AV gradient following 
Figure 3 Kaplan-Meier curve showing the difference in freedom 
from aortic insufficiency ≥2+ between Group I (PG <20 mmHg) 
and II (PG ≥20 mmHg) at different time periods
Figure 4 Kaplan-Meier curve showing the difference in freedom 
from aortic valve re-operation between Group I (PG <20 mmHg) 
and II (PG ≥20 mmHg) at different time periods
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AVr was likely to reduce its durability and freedom from 
AV re-intervention (14). High pressure across the repair 
may cause greater stress, prevent healing and lead to LV 
impairment (15,16). This seems reasonable given that raised 
transvalvular gradients are common causes of both early 
and late re-operation following AVR. Such gradients can 
develop as a result of patient-prosthesis mismatch, acute 
valve thrombosis or pannus formation. Recently, a study 
by Riegel et al. (17) considered the impact of raised intra-
operative and post-operative transvalvular gradients on early 
re-operation rate following MV repair. This study showed 
that mean and peak trans-mitral gradients of greater than 
7 and 17 mmHg respectively were associated with the need 
for MV re-intervention during the same admission. The 
authors, however, did not report any long-term outcomes. 
This is the first study of its kind comparing the effect 
of higher post-operative valve gradient on freedom 
from valve re-intervention in patients undergoing 
AVr. However, it is important to interpret this study 
in light of its limitations. First, it is a non-randomised, 
retrospective comparison of two groups of patients and 
it is possible that baseline differences in covariates and 
selection bias could have affected the findings. However, 
the data from which the study was derived was collected 
prospectively and multivariate analyses performed. Given 
the lack of well-designed comparative studies and the 
excellent modern outcomes for AVr, a randomised multi-
centre trial of AV repair versus AV replacement along 
with a sub-group analysis of high post-operative gradient 
patients seems warranted. This may be methodologically 
difficult, however, because of heterogeneity in the 
techniques and the lack of specialist centres with 
sufficient experience in the nuances of AVr. In summary, 
this study has shown that raised early post-operative 
AV gradient after AVr may be associated with worse 
freedom from AV re-intervention. Strategies to limit the 
development of the gradient and to detect its occurrence 
early are warranted. 
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